Patents by Inventor Andrea Tipold

Andrea Tipold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS
    Publication number: 20160367562
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Application
    Filed: August 30, 2016
    Publication date: December 22, 2016
    Inventors: Chris RUNDFELDT, Rita DOST, Wolfgang LOSCHER, Andrea TIPOLD, Klaus UNVERFERTH, Hans-Joachim LANKAU
  • Use of dihydroimidazolones for the treatment of dogs
    Patent number: 9469611
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: October 18, 2016
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Chris Rundfeldt, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unverferth, Hans-Joachim Lankau
  • USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS
    Publication number: 20150072983
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 12, 2015
    Inventors: Chris RUNDFELDT, Rita DOST, Wolfgang LOSCHER, Andrea TIPOLD, Klaus UNVERFERTH, Hans-Joachim LANKAU
  • Use of dihydroimidazolones for the treatment of dogs
    Patent number: 8962617
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: February 24, 2015
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Chris Rundfeldt, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unverferth, Hans-Joachim Lankau
  • Use of dihydroimidazolones for the treatment of dogs
    Patent number: 8859540
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: October 14, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Chris Rundfeldt, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unverferth, Hans-Joachim Lankau
  • USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS
    Publication number: 20130065898
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 14, 2013
    Inventors: CHRIS RUNDFELDT, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unyerferth, Hans-Joachim Lankau
  • Use of dihydroimidazolones for the treatment of dogs
    Publication number: 20080027057
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1 H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Application
    Filed: July 18, 2007
    Publication date: January 31, 2008
    Inventors: Chris Rundfeldt, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unverferth, Hans-Joachim Lankau
  • Use of dihydroimidazolones for the treatment of dogs
    Publication number: 20050070537
    Abstract: The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
    Type: Application
    Filed: October 6, 2003
    Publication date: March 31, 2005
    Inventors: Chris Rundfeldt, Rita Dost, Wolfgang Loscher, Andrea Tipold, Klaus Unverferth, Hans-Joachim Lankau